Letters from Grassley: FDA to Clarify Policies on Medical Devices
This week, Senator Charles Grassley (R-IA), ranking member of the Senate Finance Committee, issued a press release asking the Food…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
FDA
Five Part Podcast Series on FDA Features John Kamp of Coalition for…
A new five-part Podcast series was recently announced by Med Ad News editors Steven Niles and Joshua Slatko. The series will…
FDA Official Cleared of Conflict Allegations in Heparin Contamination Case
Last week Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA was cleared of a conflict of interest…
Three Felonies a Day: How the Feds Target the Innocent
Sensationalist headlines discussing large settlements from cases involving medical device and pharmaceutical companies usually…
GAO to FDA: Action Needed to Improve Timeliness on Clinical Investigator…
The Government Accounting Office ("GAO") published a new report on the oversight of clinical investigators titled,…
FDA Announces Strategic Plan for Risk Communication
The FDA today announced a Strategic Plan for Risk Communication that establishes a framework for communicating meaningful health…
FDA Hires IOM to Review Medical Device Approval System
The Food and Drug Administration (FDA) recently issued a press release announcing the commissioning of the Institute of…
Letters from Grassley: Are Statins Safe? Is the Sky Blue?
Simple questions deserve simple answers. So when Senator Grassley (R-IA) recently sent a letter to the Food and…
JAMA: HPV and Cervical Cancer Treatment Gardasil – Choosing to Ignore…
Cervical Cancer is a serious disease and the second leading cause of cancer death in women world wide. In the US it is…